603822.SH
ST嘉澳
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 57.56
+0.02%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.9B | 4.8B | 1.3B | 2.7B | 3.2B |
| Cost of Revenue | 4.1B | 4.0B | 1.3B | 2.5B | 3.0B |
| Gross Profit | 865.1M | 823.1M | (62.9M) | 140.7M | 186.4M |
| Operating Expenses | |||||
| R&D Expense | 188.9M | 172.4M | 58.5M | 42.4M | 91.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 151.8M | 142.8M | 122.4M | 90.0M | 103.7M |
| Selling & Marketing Expense | 23.0M | 22.4M | 15.5M | 12.5M | 13.0M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 581.7M | 500.6M | 289.5M | 229.0M | 276.9M |
| Cost and Expenses | 4.6B | 4.5B | 1.6B | 2.8B | 3.3B |
| Operating Income (EBIT) | 252.1M | 279.5M | (396.5M) | (36.0M) | (64.1M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 251.7M | 279.1M | (396.1M) | (34.8M) | (66.4M) |
| Income Tax Expense | (22.7M) | (11.7M) | (22.7M) | (29.6M) | (35.3M) |
| Bottom Line | |||||
| Net Income | 34.0M | 31.3M | (366.9M) | (7.5M) | (32.4M) |
| Earnings from Cont. Ops | 274.5M | 290.8M | (373.4M) | (5.2M) | (31.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 34.0M | 31.3M | (366.9M) | (7.5M) | (32.4M) |
| Per Share | |||||
| Basic EPS | CN¥0.44 | CN¥0.41 | (CN¥4.76) | (CN¥0.10) | (CN¥0.44) |
| Diluted EPS | CN¥0.44 | CN¥0.41 | (CN¥4.76) | (CN¥0.10) | (CN¥0.44) |
| Revenue Per Share | CN¥63.98 | CN¥62.88 | CN¥16.51 | CN¥34.47 | CN¥43.18 |
| Shares | |||||
| Basic Shares Outstanding | 76.8M | 76.8M | 77.1M | 77.3M | 74.4M |
| Diluted Shares Outstanding | 76.8M | 76.8M | 77.1M | 77.3M | 74.4M |
| Profitability Metrics | |||||
| EBITDA | — | 644.8M | (250.6M) | 73.4M | 170.8K |
| D&A | — | 365.3M | 145.9M | 109.4M | 64.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026